Shares of Catasys, Inc. (NASDAQ:CATS) have earned a consensus broker rating score of 1.50 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating and one has issued a strong buy rating on the company.
Analysts have set a 12-month consensus target price of $10.50 for the company and are expecting that the company will post ($0.29) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 52 out of 255 based on the ratings given to its competitors.
Several research analysts have issued reports on the stock. Canaccord Genuity assumed coverage on shares of Catasys in a report on Monday, June 18th. They issued a “buy” rating and a $10.00 target price for the company. Zacks Investment Research raised shares of Catasys from a “sell” rating to a “hold” rating in a report on Tuesday, August 21st. Finally, ValuEngine raised shares of Catasys from a “hold” rating to a “buy” rating in a report on Friday, June 1st.
An institutional investor recently bought a new position in Catasys stock. EAM Investors LLC bought a new position in Catasys, Inc. (NASDAQ:CATS) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 101,039 shares of the company’s stock, valued at approximately $679,000. EAM Investors LLC owned about 0.64% of Catasys as of its most recent filing with the Securities & Exchange Commission. 6.95% of the stock is currently owned by institutional investors.
Shares of Catasys stock opened at $10.19 on Tuesday. The company has a debt-to-equity ratio of -1.05, a quick ratio of 0.91 and a current ratio of 0.91. Catasys has a 52-week low of $3.30 and a 52-week high of $10.65.
Catasys (NASDAQ:CATS) last issued its earnings results on Tuesday, August 14th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. The business had revenue of $3.27 million during the quarter, compared to analysts’ expectations of $2.40 million. Catasys had a negative net margin of 150.62% and a negative return on equity of 546.50%. equities research analysts predict that Catasys will post -1.09 EPS for the current fiscal year.
Catasys Company Profile
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Featured Article: What is the NASDAQ Stock Market?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.